These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas. Schneider AM; Straus DJ; Schluger AE; Lowenthal DA; Koziner B; Lee BJ; Wong G; Clarkson BD J Clin Oncol; 1990 Jan; 8(1):94-102. PubMed ID: 1688617 [TBL] [Abstract][Full Text] [Related]
23. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489 [TBL] [Abstract][Full Text] [Related]
24. MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma. Marosi C; Heinz R; Steger G; Fortelny A; Chott A; Hanak H; Radaszkiewicz T; Baur M; Kreiner G; Schwarzinger I J Cancer Res Clin Oncol; 1992; 118(4):314-7. PubMed ID: 1374411 [TBL] [Abstract][Full Text] [Related]
25. MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas. Mazza P; Zinzani PL; Martelli M; Fiacchini M; Bocchia M; Pileri S; Falini B; Martelli MF; Amadori S; Papa G Leuk Lymphoma; 1995 Feb; 16(5-6):457-63. PubMed ID: 7540460 [TBL] [Abstract][Full Text] [Related]
26. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712 [TBL] [Abstract][Full Text] [Related]
27. [An apparently primary lymphoma of the testicle]. Belbusti F; Signoretti P; Tondi MR; Sparaventi G G Chir; 1991; 12(8-9):438-40. PubMed ID: 1721520 [TBL] [Abstract][Full Text] [Related]
28. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357 [TBL] [Abstract][Full Text] [Related]
29. MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection. Taillan B; Garnier G; Ferrari E; Pesce A; Vinti H; Fuzibet JG; Dujardin P Acta Haematol; 1993; 89(1):10-2. PubMed ID: 7683165 [TBL] [Abstract][Full Text] [Related]
30. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089 [TBL] [Abstract][Full Text] [Related]
31. Comparison of different treatment strategies for diffuse large-cell lymphomas: a decision analysis. Djulbegovic B; Hollenberg J; Woodcock TM; Herzig R Med Decis Making; 1991; 11(1):1-8. PubMed ID: 1709713 [TBL] [Abstract][Full Text] [Related]
32. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma. Sweetenham JW; Mead GM; Whitehouse JM J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454 [TBL] [Abstract][Full Text] [Related]
33. The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients. Broccoli A; Casadei B; Stefoni V; Pellegrini C; Quirini F; Tonialini L; Morigi A; Marangon M; Argnani L; Zinzani PL BMC Cancer; 2017 Apr; 17(1):276. PubMed ID: 28415982 [TBL] [Abstract][Full Text] [Related]
36. [Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma]. Okubo Y; Nakazawa K Rinsho Ketsueki; 1993 Apr; 34(4):473-7. PubMed ID: 7685433 [TBL] [Abstract][Full Text] [Related]